Delivery Order SPE2DB22D2006-SPE2DB25FW2XR
- Not listed
- The Defense Logistics Agency awarded a $1,487.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Nexlizet 180-10 mg tablets in quantities of 30, with an ultimate completion date of July 28, 2025. This non-competitive, non-set-aside delivery order was issued on July 25, 2025, and represents a routine pharmaceutical supply transaction to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,364.32, is for the supply of the drug NEXLIZET 180-10 MG TABLET to support U.S. military and federal healthcare programs. It is a firm-fixed-price contract with an ultimate completion date of August 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NEXLIZET 180-10 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $2,250.74. The contract is a firm fixed price delivery order with an ultimate completion date of July 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of NEXLIZET 180-10 MG TABLET UU 30S, with a total ceiling value of $2,796.76 and a period of performance through February 28, 2024. The contract is a firm fixed price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,768.56 with a firm fixed price. It covers the supply of NEXLIZET 180-10 MG TABLET for the DLA, with an ultimate completion date of April 1, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at four hundred thirty-eight dollars and thirty-seven cents ($438.37) to Amerisourcebergen Drug Corporation for the supply of thirty (30) Nexlizet 180-10 mg tablets. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 2nd to August 3rd, 2023. The delivery order was placed against an existing DLA medical supply vehicle and provides pharmaceutical products...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NEXLIZET 180-10 MG TABLET, a pharmaceutical product, with a ceiling value of $2,094.14 and a performance period through July 1, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NEXLIZET 180-10 MG TABLET, with a ceiling value of $3,085.52 and a completion date of September 14, 2023. The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
- This federal contract award is for the delivery of pharmaceutical products, specifically NEXLIZET 180-10 MG TABLET, to the Medical Supply Chain component of the Defense Logistics Agency (DLA). The fixed-price contract, valued at $1,861.46, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
- This federal contract award, valued at $1,473.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NEXLIZET 180-10 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of July 19, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2XRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Nexlizet 180-10 mg tablets in a quantity of 30 units, with a ceiling value of $1,201.20. This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive pharmaceutical supply vehicle enabling the contractor to deliver a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen's status as a major pharmaceutical distributor and established federal contractor demonstrates its capability to meet the Defense Logistics Agency's pharmaceutical procurement requirements across multiple therapeutic domains for defense and military healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/28/25 |